Irving E. Vega

Tanycytic ependymoma in a 76-year-old Puerto Rican male.

Profiling of Alzheimer's disease patients in Puerto Rico: A comparison of two distinct socioeconomic areas.

EFhd2, a Protein Linked to Alzheimer's Disease and Other Neurological Disorders.

Labeling Pathological Tau: An Important Quest for the Unknown.

Diversity is Inclusion.

Editorial: Unraveling Neuroprotective and Neurodegenerative Signals in Neurodegeneration.

Biomarkers for the Early Detection and Progression of Alzheimer's Disease.

Oxidative stress in neurodegenerative disease: causation or association?

Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.

A START-domain-containing protein is a novel marker of nervous system components of the sea cucumber Holothuria glaberrima.

Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.

EF Hand Domain Family Member D2 Is Required for T Cell Cytotoxicity.

A functional proteomics platform to reveal the sequence determinants of lysine methyltransferase substrate selectivity.

Tau's Three-Repeat Domain and EFhd2 Co-incubation Leads to Increased Thioflavin Signal.

Tau13 Antibody Preferentially Immunoprecipitates High Molecular Weight Tau Proteins.

EFhd2 Affects Tau Liquid-Liquid Phase Separation.

Age of Migration and Cognitive Function Among Older Latinos in the United States.

Validation of recombinant human protein purified from bacteria: An important step to increase scientific rigor.

Partnering with Middle Eastern/Arab American and Latino Immigrant Communities to Increase Participation in Alzheimer's Disease Research.

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease.

Glycosylated hemoglobin level, race/ethnicity, and cognition in midlife and early old age.

Structure of an AMPK complex in an inactive, ATP-bound state.

EFhd2 brain interactome reveals its association with different cellular and molecular processes.

Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane.

Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein.